rs768594224
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_000260.4(MYO7A):c.5169-6C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000502 in 1,395,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000260.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.5169-6C>A | splice_region_variant, intron_variant | Intron 37 of 48 | 1 | NM_000260.4 | ENSP00000386331.3 | |||
MYO7A | ENST00000458637.6 | c.5055-6C>A | splice_region_variant, intron_variant | Intron 37 of 48 | 1 | ENSP00000392185.2 | ||||
MYO7A | ENST00000409619.6 | c.5022-6C>A | splice_region_variant, intron_variant | Intron 38 of 49 | 1 | ENSP00000386635.2 | ||||
MYO7A | ENST00000458169.2 | c.2595-6C>A | splice_region_variant, intron_variant | Intron 17 of 28 | 1 | ENSP00000417017.2 | ||||
MYO7A | ENST00000670577.1 | n.3009-6C>A | splice_region_variant, intron_variant | Intron 20 of 31 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000502 AC: 7AN: 1395296Hom.: 0 Cov.: 31 AF XY: 0.00000581 AC XY: 4AN XY: 688278
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Nonsyndromic genetic hearing loss Uncertain:1
This sequence change in MYO7A is an intronic variant located in intron 37. This variant is absent from gnomAD v2.1 and v3.1. To our knowledge, this variant has not been reported in the literature in any individuals with MYO7A-related disease. The results from multiple in silico splicing predictors (SpliceAI, MaxEntScan) support neither a deleterious nor benign impact on the acceptor splice site of intron 37 of MYO7A. Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.